Stock listing

Formycon Ag

Selected listing: FYB · GETTEX · EUR · DE

Formycon Ag (gettex:FYB), Health Technology. Latest release Oct 6, 2026: Formycon Optimizes Biosimilar Development with AI-Powered Technologies: Digital…

FYB:GETTEXEURDEUpdated September 25, 2026

Ticker: gettex:FYB
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: gettex
Currency: EUR

About Formycon Ag

The company focuses on the development of biosimilars and biopharmaceuticals, aiming to provide affordable treatment options in the healthcare sector. Formycon is committed to advancing its innovative product pipeline to meet the needs of patients and healthcare providers.

Latest news from Formycon Ag

Formycon Optimizes Biosimilar Development with AI-Powered Technologies: Digital Solutions Enhance Development Efficiency as Part of the FYB4GROWTH Strategy

October 6, 2026

Formycon sets Benchmark in Biosimilar Development: Scientific Foundation of the innovative Development Program for FYB206 published in the Journal BioDrugs

September 22, 2026

Formycon reports key operational achievements in the first half of 2026 and significantly improves financial results year-on-year

August 12, 2026

Formycon invites to conference call on 2026 half-year results and announces participation in international investor conferences

August 5, 2026

Formycon AG and OneSource Specialty Pharma announce strategic Manufacturing Partnership for Biosimilars

July 14, 2026

All Formycon Ag news →

Research Formycon Ag

Formycon Ag company profile

View the public company page for Formycon Ag on 6ix.

Formycon Ag news

Read company news and market updates connected to Formycon Ag.

Formycon Ag investor events

Find investor webinars, events, and replay context for Formycon Ag.